SureTrader SureTrader
Home > Boards > US Listed > Medical - Drugs >

Apricus Biosciences, Inc. (APRI)

APRI RSS Feed
Add APRI Price Alert      Hide Sticky   Hide Intro
Moderator: carlodb1978, mecosmo2, Chillin up north
Search This Board:
Last Post: 12/9/2016 8:42:39 AM - Followers: 188 - Board type: Free - Posts Today: 1

Apricus Biosciences, Inc. (APRI) 

 

 

http://www.apricusbio.com/

 

 

 

 

Company Address:

11975 El Camino Real, Suite 300
San Diego, CA 92130
T (858) 222-8041

 CIK:   0001017491

Apricus Website:    http://www.apricusbio.com/index.html

 

 
 

NexACT® - Multi-Route Drug Delivery Technology

NexACT® Multi-Route drug delivery technology facilitates compounds crossing the lipid bilayer and yet biodegrades in vivo to natural amino acids and natural fatty acids.

This technology is useful for:
  • Penetrating, proprietary, topical & transdermal formulations.
    Improving oral bioavailability of poorly soluble, poorly permeating compounds (BCS class 2-4)
    Delivering siRNA therapeutics into the cells; in vivo validated
    Development of more effective, penetrating cosmeceutic formulations
    Preservative

The safety and permeation properties of this proprietary drug delivery technology was demonstrated in the Vitaros® product which was approved for the treatment of erectile dysfunction in November 2010 by Health Canada, and approved by the European Union in June 2013.  Vitaros has been launched in all European Union countries by partner pharmaceutical companies.  Additional agreements for marketing Vitaros have been established.  For more information see the company's most recent 10K SEC filing.

In September 2015 the company anounced an agreement with Allergan to reacquire marketing rights for Vitaros in the U.S.  The company expects to resubmit a filing for FDA approval of Vitaros in the second half of 2016.  For more information see the company's most recent 10K SEC filing.


The company expects to initiate a Phase IIb clinical trial for RayVa to treat Reynaud's Syndrome in the second half of 2016.

In October 2014, the company acquired U.S. development and licensing rights to Fispemifene, a Selective Estrogen-Receptor Modulator (SERM) for treatment of secondary hypogonadism.  In March 2016 the company discontinued development Fispemifene after disappointing Phase IIb results.
.

 Filings:  http://www.sec.gov/cgi-bin/browse-edgar?company=&match=&CIK=0001017491&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany

Share Structure:
Outstanding Shares
 61,78M

Authorized Shares
75,000,000
  

Investor Relations:
ir@apricusbio.com
Tel: +1-858 222-8041

Matthew Beck
The Trout Group
:(646)378 2933

 

 

 

All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.

 

Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp

 


                                                                           
Image result for vitaros                                                  

Image result for vitaros

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
APRI
Current Price
Volume:
Bid Ask Day's Range
SureTrader
APRI News: Apricus Biosciences Receives Nasdaq Compliance Notice 12/01/2016 07:00:29 AM
APRI News: Apricus Biosciences Receives Nasdaq Compliance Notice 12/01/2016 07:00:00 AM
APRI News: Current Report Filing (8-k) 12/01/2016 06:03:41 AM
APRI News: Apricus Biosciences to Present at the 9th Annual LD Micro Main Event 11/29/2016 07:00:26 AM
APRI News: Apricus Biosciences to Present at the 9th Annual LD Micro Main Event 11/29/2016 07:00:00 AM
PostSubject
#26588   I don't think that is the plan at casinokid11211 12/09/16 08:42:39 AM
#26587   Interesting article about the man they say Trump PuuliTuku 12/08/16 04:04:39 PM
#26586   First, IR is paid (somehow) by the company DavenCT 12/08/16 02:59:08 PM
#26585   That was the plan all along. They milked Gup80 12/08/16 02:50:05 PM
#26584   So, I just got a response from IR. Sljivo 12/08/16 01:48:22 PM
#26583   I think it will go below a buck tomorrow. casinokid11211 12/08/16 12:57:48 PM
#26582   Who would buy $25M of this dog? growtheport 12/07/16 02:00:43 PM
#26581   25 million new shares at $1.05 will put roundbox52 12/07/16 01:56:43 PM
#26580   No way Pascoe can dilute on 7.7 million casinokid11211 12/07/16 01:45:49 PM
#26579   I sold part Part is still in but i carlodb1978 12/07/16 01:31:33 PM
#26578   You still "believe"? After being screwed so many Reaver04 12/07/16 01:29:56 PM
#26577   From the presentation ryva is out for december Profitability carlodb1978 12/07/16 01:08:23 PM
#26575   reaver is that a serious question???? shaggy2691 12/05/16 06:49:47 PM
#26574   Would that be $1 Pre-split? Reaver04 12/05/16 04:35:48 PM
#26572   Agree with roundbox and casinokid shaggy2691 12/05/16 03:20:08 PM
#26571   In order to reach a 35M market cap roundbox52 12/05/16 01:12:35 PM
#26570   One way is Denner starts a run by mecosmo2 12/04/16 10:33:04 AM
#26569   How does APRI get the market cap to casinokid11211 12/04/16 07:07:58 AM
#26567   I would think Trump had way more important nsomniyak 12/02/16 04:17:26 PM
#26566   Hi, Aprilov. Sljivo 12/02/16 03:07:20 PM
#26565   Hello Aprilov 12/02/16 02:00:02 PM
#26563   Where is Denner? RVL 12/01/16 09:36:33 PM
#26562   Lol, the dual alias Even as the future Strong long 12/01/16 08:00:05 PM
#26561   Here comes below $1... Reaver04 12/01/16 06:34:37 PM
#26560   Wow we reached 10 mlns carlodb1978 12/01/16 04:07:30 PM
#26559   So in what ways can we seriously expect roundbox52 12/01/16 01:17:45 PM
#26558   I just spoke to the guy who answers SocialBoom 12/01/16 11:25:18 AM
#26556   Thanks for the information. Perfectshot23 11/30/16 05:30:24 PM
#26555   Yo mean gene shaggy2691 11/30/16 02:57:45 PM
#26554   Ok Here is the scoop shaggy2691 11/30/16 02:53:12 PM
#26553   Shaggy, what is your average cost per share? mean gene 11/30/16 02:38:30 PM
#26552   Imho it would rather be a miracle if PuuliTuku 11/30/16 01:43:41 PM
#26551   left message for Pascoe regarding delisting---no answer yet shaggy2691 11/30/16 01:40:54 PM
#26549   ETA if they get an extension or not? Tomorrow'ish? PuuliTuku 11/29/16 12:58:46 PM
#26548   Apricus Biosciences to Present at the 9th Annual mecosmo2 11/29/16 07:28:09 AM
#26546   JBS USA Holdings, Inc.I believe they are into Pork! mecosmo2 11/28/16 04:20:48 PM
#26545   Reads like Pascoe gibberish. Who is JBS Inc? growtheport 11/28/16 01:23:48 PM
#26544   Interesting post by. .JBS Inc. mecosmo2 11/28/16 09:49:55 AM
#26541   New controller appointed carlodb1978 11/26/16 08:57:52 AM
#26540   Just one very, very,very,very, minor detail casinokid11211 11/26/16 05:39:22 AM
#26539   While it appears there are conflicts of interest growtheport 11/25/16 10:35:44 PM
#26538   There are rumors but so far no convictions mecosmo2 11/25/16 10:42:14 AM
#26537   Carlo, I really doesn't think it matters after casinokid11211 11/25/16 06:59:53 AM
#26536   Mecosmo, I could read on other boards FDA Clariske 11/25/16 01:06:21 AM
#26535   sorry and do u really believe Sarissa wonna carlodb1978 11/24/16 10:02:14 AM
#26534   Carlo, Sarissa is no longer involved and has casinokid11211 11/24/16 06:32:04 AM
#26533   For me the company is for sales Sarissa has carlodb1978 11/23/16 01:17:20 PM
#26532   Hard to say if this is a cost growtheport 11/23/16 11:29:04 AM
#26531   As of Weds Nov 30, APRI will be casinokid11211 11/23/16 06:52:45 AM
#26530   Sarissa avg price is pretty high. A small Reaver04 11/23/16 12:48:15 AM
PostSubject